20-Gy single-fraction as HDR Monotherapy For Low And Intermediate Prostate Cancer: Clinical Outcomes And Toxicity Profile

2020 
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    0
    Citations
    NaN
    KQI
    []